Online Only Articles

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

NHS Blood and Transplant, Birmingham, UK;School of Cancer Sciences, University of Birmingham, Birmingham, UK
School of Cancer Sciences, University of Birmingham, Birmingham, UK
School of Cancer Sciences, University of Birmingham, Birmingham, UK
School of Cancer Sciences, University of Birmingham, Birmingham, UK;Centre for Clinical Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Cancer Sciences, University of Birmingham, Birmingham, UK;Centre for Clinical Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
NHS Blood and Transplant, Birmingham, UK;School of Cancer Sciences, University of Birmingham, Birmingham, UK;Centre for Clinical Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Vol. 100 No. 8 (2015): August, 2015 https://doi.org/10.3324/haematol.2015.123687